IQVIA Holdings Inc.
IQVNYSEHealthcare● Active
$183.45
$-3.43(-1.84%)
Market Cap$30.6B
P/E Ratio—
52W High$247.05
52W Low$146.44
IQVIA Holdings Inc. (IQV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IQV · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$2.90
Est. $2.82 · +2.8%
Revenue
$4.15B
Est. $4.10B · +1.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 11-Quarter EPS Beat Streak
IQV reports quarterly as a NYSE-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 28, 2026 | $3.03 | — | — | — | $4.31B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $2.82 | $2.90 | +2.8% | $4.15B | $4.10B | +1.2% |
| — Q1 FY2026 | Feb 5, 2026 | $3.40 | $3.42 | +0.6% | $4.36B | $4.24B | +2.9% |
| — Q4 FY2025 | Oct 28, 2025 | $2.98 | $3.00 | +0.7% | $4.10B | $4.08B | +0.5% |
| ▲ Q3 FY2025 | Jul 22, 2025 | $2.77 | $2.81 | +1.4% | $4.02B | $3.97B | +1.2% |
| ▲ Q2 FY2025 | May 6, 2025 | $2.63 | $2.70 | +2.7% | $3.83B | $3.77B | +1.5% |
| — Q1 FY2025 | Feb 6, 2025 | $3.11 | $3.12 | +0.3% | $3.96B | $3.93B | +0.8% |
| — Q4 FY2024 | Oct 31, 2024 | $2.82 | $2.84 | +0.7% | $3.90B | $3.87B | +0.8% |
Q3 FY2026
Jul 28, 2026
EPS Actual
—
EPS Est.
$3.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$2.90
EPS Est.
$2.82
EPS Surpr.
+2.8%
Revenue
$4.15B
Q1 FY2026
Feb 5, 2026
EPS Actual
$3.42
EPS Est.
$3.40
EPS Surpr.
+0.6%
Revenue
$4.36B
Q4 FY2025
Oct 28, 2025
EPS Actual
$3.00
EPS Est.
$2.98
EPS Surpr.
+0.7%
Revenue
$4.10B
Q3 FY2025
Jul 22, 2025Beat
EPS Actual
$2.81
EPS Est.
$2.77
EPS Surpr.
+1.4%
Revenue
$4.02B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$2.70
EPS Est.
$2.63
EPS Surpr.
+2.7%
Revenue
$3.83B
Q1 FY2025
Feb 6, 2025
EPS Actual
$3.12
EPS Est.
$3.11
EPS Surpr.
+0.3%
Revenue
$3.96B
Q4 FY2024
Oct 31, 2024
EPS Actual
$2.84
EPS Est.
$2.82
EPS Surpr.
+0.7%
Revenue
$3.90B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $5.21 | $5.27 | $5.36 | 10 |
| Q3 FY2029 | $4.82 | $4.87 | $4.96 | 9 |
| Q2 FY2029 | $4.42 | $4.47 | $4.55 | 9 |
| Q1 FY2029 | $4.20 | $4.25 | $4.32 | 10 |
| Q4 FY2028 | $4.36 | $4.41 | $4.49 | 7 |
| Q3 FY2028 | $3.91 | $3.95 | $4.02 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2029 | $5.0B | $5.0B | $5.1B | 5 |
| Q3 FY2029 | $4.8B | $4.9B | $4.9B | 5 |
| Q2 FY2029 | $4.8B | $4.8B | $4.9B | 8 |
| Q1 FY2029 | $4.6B | $4.7B | $4.7B | 6 |
| Q4 FY2028 | $4.9B | $5.0B | $5.0B | 4 |
| Q3 FY2028 | $4.8B | $4.8B | $4.9B | 9 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +2.8% | $160.94 | $176.42 | +9.62% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +0.6% | $202.54 | $180.96 | -10.65% |
| ▲ Q4 FY2025 | Oct 28, 2025 | +0.7% | $217.43 | $218.13 | +0.32% |
| ▲ Q3 FY2025 | Jul 22, 2025 | +1.4% | $158.96 | $187.38 | +17.88% |
| ▲ Q2 FY2025 | May 6, 2025 | +2.7% | $152.30 | $146.20 | -4.01% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +0.3% | $205.44 | $209.96 | +2.20% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +0.7% | $216.04 | $205.82 | -4.73% |
| ▲ Q3 FY2024 | Jul 22, 2024 | +3.1% | $224.57 | $245.23 | +9.20% |
Q2 FY2026+9.62%
Report Date
May 5, 2026
EPS Beat/Miss
+2.8%
Price Before
$160.94
Price After
$176.42
Q1 FY2026-10.65%
Report Date
Feb 5, 2026
EPS Beat/Miss
+0.6%
Price Before
$202.54
Price After
$180.96
Q4 FY2025+0.32%
Report Date
Oct 28, 2025
EPS Beat/Miss
+0.7%
Price Before
$217.43
Price After
$218.13
Q3 FY2025+17.88%
Report Date
Jul 22, 2025
EPS Beat/Miss
+1.4%
Price Before
$158.96
Price After
$187.38
Q2 FY2025-4.01%
Report Date
May 6, 2025
EPS Beat/Miss
+2.7%
Price Before
$152.30
Price After
$146.20
Q1 FY2025+2.20%
Report Date
Feb 6, 2025
EPS Beat/Miss
+0.3%
Price Before
$205.44
Price After
$209.96
Q4 FY2024-4.73%
Report Date
Oct 31, 2024
EPS Beat/Miss
+0.7%
Price Before
$216.04
Price After
$205.82
Q3 FY2024+9.20%
Report Date
Jul 22, 2024
EPS Beat/Miss
+3.1%
Price Before
$224.57
Price After
$245.23
Avg Beat Reaction+2.48%
Beat Rate8 / 8 quarters
Largest Move+17.88% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IQV ends December
IQVIA Holdings Inc. (IQV) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $2.90 — beating the analyst consensus of $2.82 by +2.8%. IQV has beaten EPS estimates for 11 consecutive quarters. The next IQV earnings date is expected around September 1, 2026.
Each quarter, investors track IQV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IQV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IQV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IQV earnings · 5 questionsIQVIA Holdings Inc.'s next earnings report is expected around September 1, 2026. IQV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IQV historically reports after market close (AMC).
IQV earnings datewhen is IQV earningsIQV next earnings datewhen does IQV report earningsIQV earnings calendar
▸ Source: FMP · IQVIA Holdings Inc. SEC filings · US GAAP · IQVIA Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026